A federal bill would expand access to experimental treatments, but critics say right to try would take away FDA oversight and create a ‘Wild West.’ Meanwhile, most states’ right-to-try laws have gone unused.
They take the brakes off the immune system so it attacks cancer cells. But many people don’t respond to checkpoint inhibitors, so researchers are looking for ways to defeat the resistance.
Thirty-nine states had contracts with comprehensive risk-based Medicaid managed care organizations and in 29 of those states, 75% or more of the Medicaid beneficiaries were enrolled in one of those organizations. A large majority (27 of 32) of the Medicaid expansion states used managed care organizations to cover newly eligibly adults.
At last count, the pharmaceutical industry’s new product pipeline included more than 7,000 products in late-stage development, roughly half of which are deemed “specialty.” The reality is, our health care system is poorly equipped to address this issue head-on.
A British study of 296,535 people added to evidence that the so-called obesity paradox—that being overweight or obese does not necessarily mean a greater chance of getting a heart attack—simply does not exist. Many of us could stand to lose a few pounds to lower our cardiovascular risk.
Cancer survivors were better able to afford care and did not see delays in treatment from 2010 through 2016, the years when the ACA was phased in. But researchers were unable to make a definite connection because many of the ACA’s coverage changes did not come about until January 2014.
Employers and health insurers are asking consumers to put ‘more skin in the game’ with high-deductible health plans but don’t provide incentives for them to choose high-value care.
Are we seeing the beginning of the end of the independent physician? Between July 2015 and July 2016, U.S. hospitals bought up 5,000 independent physician practices. In 2012, about 14% of practices were owned by hospitals. Four years later, that percentage had more than doubled to 29%.
Roughly one in 20 women of childbearing age suffer from major depression. Women without private health insurance had a 2.5-fold increased risk of major depression. The antidepressants most commonly used by women with major depression were selective serotonin reuptake inhibitors (21.3%), phenylpiperazines (8.4%), and serotonin-norepinephrine reuptake inhibitors (7.2%).
New guidelines from the American College of Physicians recommend less stringent blood sugar targets for most people with diabetes. Other professional groups think that’s a terrible idea.
There are four barriers to improving colorectal care for poor people. They are: limited resources, whether patients understand colorectal symptoms and physicians correctly diagnose them, beliefs about health and illness such as self-care, and patients’ reaction to illness.
Compared with control groups, the SGLT-2 inhibitors and GLP-1 agonists were associated with reductions in all-cause mortality—and researchers had set all-cause mortality as the primary outcome for the meta-analysis. As for the DPP-4 inhibitors, they identified an association with a small increase (0.1%) in all-cause mortality compared with controls.